Click here to sign in with or
Forget Password?
Learn more
share this!
Share
Twit
Share
Email
July 3, 2024
This article has been reviewed according to Science X’s editorial process and policies. Editors have highlighted the following attributes while ensuring the content’s credibility:
fact-checked
trusted source
written by researcher(s)
proofread
by Colin Davidson, The Conversation
Psilocybin, a compound found in many types of mushrooms, is an antidepressant with potential use in treating anxiety. Unfortunately, unscrupulous vendors have used these clinical results to sell products made from an unrelated and somewhat toxic mushroom: Amanita muscaria.
In a recent study, researchers at the University of California, San Diego, found a significant increase in interest in this mushroom—noting a 114% rise in Google searches from 2022 to 2023.
So what is this mushroom and why is there cause for concern?
A muscaria or “fly agaric” is found in temperate and sub-Arctic zones across the northern hemisphere. For millennia, shamans from various regions—from Lapland to Siberia—have used the mushroom in their rituals, helping them achieve a mental state similar to that achieved with other psychedelics.
The active ingredients in these mushrooms are muscimol and ibotenic acid, which are entirely different compounds to psilocybin. Today, products containing muscimol, such as gummies, tinctures and capsules, are being sold with vague promises of better health.
The brain contains chemical messengers called neurotransmitters, and muscimol acts on one of these transmitter “receptors” (Gaba-A) to dampen brain activity. Gaba is the brain’s brakes—or in the jargon “inhibitory neurotransmitter.” Consequently, drugs that act on Gaba-A receptors have been used for anxiety, epilepsy and pain—conditions associated with an over-stimulated brain.
Muscimol can be considered to have a similar effect as anti-anxiety drugs known as benzodiazepines (Valium, being an example).
There have been relatively few reported cases of muscimol poisoning from fly agaric mushrooms. Most cases report gastrointestinal upset, but not death.
The other compound found in fly agaric, ibotenic acid, is structurally similar to the neurotransmitter glutamate. If Gaba is the brain’s brakes, you can think of glutamate as its accelerator.
Like glutamate, ibotenic acid can be toxic in high concentrations. In fact, ibotenic acid is used to kill brain cells in rodent experiments where small parts of the brain are destroyed in an attempt to understand what that brain area does.
It is highly unlikely that ibotenic acid has any health benefits. However, it is doubtful whether eating these mushrooms will kill brain cells because, within about an hour of ingestion, most of the ibotenic acid is excreted in the urine.
Muscimol and ibotenic acid have been found to have a relatively low lethal dose. Testing in mice found the LD50 (“lethal dose, 50%”), where half the mice are dead when given these substances orally, to be 22mg and 38mg per kilogram of body weight, respectively. The LD50 is much lower than for many other commonly taken substances: cocaine (99mg/kg), morphine (524mg/kg) and ethanol (alcohol, 3,450mg/kg).
While few deaths from fly agaric have been reported, a recent case described the death of a 44-year-old man after eating these mushrooms. The man had a heart attack about 10 hours after eating four to five mushroom caps. Although he was resuscitated, he remained unresponsive and died nine days later.
Psilocybin is a compound found in a large variety of “magic mushrooms,” but not in fly agaric. After consumption, the body converts psilocybin to psilocin. Psilocin activates the neurotransmitter serotonin’s 5-HT2A receptors in a similar way to LSD. Meta-analyses, where the data from multiple clinical trials are combined and re-analyzed, find psilocybin to be an effective antidepressant.
Harms of therapeutic doses of psilocybin have been reviewed and the most common are headache, nausea, anxiety, dizziness and high blood pressure. They tend to be well-tolerated and resolve within a couple of days.
Taken together then, we can see that fly agaric is not at all similar to psilocybin-containing mushrooms.
While psilocybin has now been shown to have good clinical use, there is no such evidence for fly agaric. Although muscimol has been shown to have some positive effects in animal studies of stroke and some other neurological illnesses, these findings have not yet been replicated in humans.
In most countries, fly agaric, muscimol and ibotenic acid are not controlled substances and people are allowed to grow, pick, buy, sell and consume them. Although consumption is rarely fatal, there are dangers associated with eating them. The practice of selling these products to unwitting consumers, who anticipate health benefits similar to psilocybin, needs to be addressed.
This article is republished from The Conversation under a Creative Commons license. Read the original article.
Explore further
Facebook
Twitter
Email
Feedback to editors
8 hours ago
0
Jul 2, 2024
0
Jul 1, 2024
0
Jun 29, 2024
0
Jun 28, 2024
0
54 minutes ago
54 minutes ago
3 hours ago
3 hours ago
3 hours ago
4 hours ago
4 hours ago
5 hours ago
5 hours ago
5 hours ago
Jun 11, 2024
Apr 23, 2024
Jul 1, 2024
Mar 19, 2024
May 13, 2024
May 22, 2024
54 minutes ago
5 hours ago
3 hours ago
8 hours ago
8 hours ago
8 hours ago
Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use our contact form. For general feedback, use the public comments section below (please adhere to guidelines).
Please select the most appropriate category to facilitate processing of your request
Thank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.
Your email address is used only to let the recipient know who sent the email. Neither your address nor the recipient’s address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.
Get weekly and/or daily updates delivered to your inbox. You can unsubscribe at any time and we’ll never share your details to third parties.
More information Privacy policy
We keep our content available to everyone. Consider supporting Science X’s mission by getting a premium account.
Daily science news on research developments and the latest scientific innovations
The latest engineering, electronics and technology advances
The most comprehensive sci-tech news coverage on the web